Radius Health (RDUS) Misses Q3 EPS by 5c

Radius Health (NASDAQ: RDUS) reported Q3 EPS of ($1.31), $0.05 worse than the analyst estimate of ($1.26). Revenue for the quarter came in at $13.47 million versus the consensus estimate of $6.75 million.

For earnings history and earnings-related data on Radius Health (RDUS) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c